ACC-1898

· AccSalus Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACC-1898, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]